Dr. Ali Nasrallah is a postdoctoral researcher at the Institute of Stem Cells for the Treatment and Study of Monogenic Diseases (I-STEM) with five years of specialized experience in skin research. He received his PhD from the University of Grenoble Alpes in France and performed his first postdoc at the Bordeaux Institute of Oncology. His work focuses on Xeroderma Pigmentosum (XP), investigating disruptions in molecular mechanisms and signaling pathways related to inflammation and pigmentation, with the aim of identifying novel therapeutic targets. To support this research, he utilizes a range of experimental models, including 3D reconstructed skin, mice, and Xenopus, to advance both the understanding and treatment of XP.
Dr. Ali Nasrallah is a postdoctoral researcher at the Institute of Stem Cells for the Treatment and Study of Monogenic Diseases (I-STEM) with five years of specialized experience in skin research. He received his PhD from the University of Grenoble Alpes in France and performed his first postdoc at the Bordeaux Institute of Oncology. His work focuses on Xeroderma Pigmentosum (XP), investigating disruptions in molecular mechanisms and signaling pathways related to inflammation and pigmentation, with the aim of identifying novel therapeutic targets. To support this research, he utilizes a range of experimental models, including 3D reconstructed skin, mice, and Xenopus, to advance both the understanding and treatment of XP.